Spruce resin and Boswellia resin – how do they differ?

Spruce resin and Boswellia resin are both natural tree resins, but chemically they are not simply two versions of the same material. Spruce resin comes from Norway spruce (Picea abies), whereas Boswellia resin is produced by different species of the genus Boswellia. They differ both in the structure of the resin material and in their main groups of non-volatile constituents.

The difference between the two therefore cannot be reduced to one characteristic compound. They are two chemically distinct natural systems whose biological profiles partly overlap but also have different areas with the strongest research support. Findings about one resin therefore cannot automatically be applied to the other.

Before comparing the two, it is important to clarify what “resin” actually means in a particular study. Spruce resin and Boswellia resin are natural materials, but scientific literature often uses the same general term for quite different samples and preparations.

In the case of spruce resin, research may concern fresh oleoresin, aged resin, wound or callus resin, purified resin material, or individual resin acids. These materials can differ considerably in their proportions of volatile terpenes, resin acids, oxidised resin-acid derivatives, lignans and hydroxycinnamic compounds.

Similar caution is especially important with Boswellia resin. Studies may investigate raw oleo-gum-resin, ethanolic or other extracts, standardised extracts, essential oil, or individual boswellic and related triterpenic acids. Chemical profiles also differ substantially between species of the genus Boswellia.

In this article, references to spruce resin and Boswellia resin therefore generally mean the natural resin materials and their characteristic chemical groups. Where a finding comes from a study of an extract, an isolated compound or a particular preparation, it should be understood as evidence about that specific material rather than automatically about the whole resin.

The greatest chemical difference between spruce resin and Boswellia resin lies in the structure of their non-volatile fractions. In spruce resin, diterpene resin acids and their modified forms are particularly important, whereas a major characteristic part of Boswellia’s non-volatile chemistry consists of pentacyclic triterpenic acids. In both materials, however, the actual composition is considerably more complex.

Spruce resin does not have one fixed composition

Fresh spruce exudate is an oleoresin containing volatile terpenes and a non-volatile resin fraction. Characteristic non-volatile constituents include diterpene resin acids of the abietane and pimarane types, such as abietic, dehydroabietic, pimaric, isopimaric, levopimaric, palustric and neoabietic acids. Their oxidised derivatives may also be important.

Spruce resin is not simply a mixture of resin acids. In one well characterised purified Picea abies resin material, the approximate composition was estimated at about 60% resin acids, 30% lignans and 10% p-coumaric acid. This is not a universal composition of spruce resin, but it illustrates how important other non-volatile groups of compounds can be.

The difference can be even greater in wound or callus resin. Research has shown that such material may be particularly rich in lignans and hydroxycinnamic compounds while containing very little of the classical resin acids. The term “spruce resin” alone therefore does not define an exact chemical profile.

Ageing changes the chemical balance of spruce resin

When resin remains exposed to air, light and the environment, some of the volatile terpenes are gradually lost and the non-volatile fraction becomes relatively more important. Oxidative changes also occur, producing additional resin-acid derivatives.

Aged resin is therefore not simply “fresh resin without its smell”. It may have a different balance of resin acids, oxidised derivatives, lignans and other non-volatile constituents.

Boswellia resin has a different chemical architecture

Resins of the genus Boswellia are oleo-gum-resins. In addition to a volatile oily fraction, they contain a non-volatile resin fraction and an important gum or polysaccharide fraction.

The non-volatile resin fraction is characterised especially by pentacyclic triterpenic acids. Boswellic acids are the best known, but they do not represent the entire chemical profile. Lupeolic, tirucallic and other related triterpenoid compounds are also present.

Boswellia resin also has no single “standard” natural composition. The proportions of individual compounds differ between Boswellia species and between individual samples of the same species. A high level of one boswellic acid therefore does not, by itself, describe the complete chemical or biological profile of the resin.

The main difference: diterpene versus triterpene chemical space

The most useful simplification is therefore that spruce resin is strongly associated with a diterpene resin-acid system, whereas Boswellia resin is characterised by a pentacyclic triterpene system.

This is a substantial chemical difference, not merely a different proportion of similar substances. It provides a sound reason to investigate whether the two resins also have partly different biological profiles. Chemical difference alone, however, does not establish which resin is more effective for a particular purpose.

Research exists for both resins, but their evidence bases are structured quite differently. For spruce resin, much of the evidence concerns microorganisms, biofilms and the biology of skin and wounds, whereas Boswellia research is more broadly developed around triterpenic acids, inflammatory mediators, immune responses and clinical studies of various extracts.

Spruce resin: from microbes to tissue responses

One of the best studied areas for spruce resin and related conifer resin materials is antimicrobial activity. Laboratory studies include bacteria, dermatophytes, yeasts and biofilms. An important finding is that the test system itself can strongly affect the result: a poorly water-soluble resin material may behave very differently in agar than in direct contact or in an appropriate emulsion.

Another important area is tissue biology. Spruce-derived materials and individual resin compounds have been investigated in preclinical models of re-epithelialisation, keratinocyte migration, fibroblast responses and angiogenesis. This shows that the research profile of spruce resin is not limited to antimicrobial activity.

Spruce resin is also notable for having direct, although limited, human clinical evidence. Preparations containing Norway spruce (Picea abies) resin have been studied in the care of chronic and difficult wounds. This represents a higher level of evidence than laboratory models, but it primarily applies to the particular preparations and conditions that were studied.

A more detailed overview is available on the page about scientific research on spruce resin.

Boswellia: from extracts to inflammatory and lipid mediators

A large part of the Boswellia research literature concerns extracts and individual triterpenic acids rather than raw resin itself. Species are not interchangeable either: most human clinical evidence is associated particularly with extracts of Boswellia serrata.

Clinical research is especially extensive in osteoarthritis and joint symptoms, but the mechanistic research landscape is considerably broader. Investigated pathways include PGE2 and mPGES-1, neutrophil enzymes, cytokine responses and lipid-mediator metabolism.

More recent research is particularly interesting because of its focus on resolution of inflammatory responses. Some Boswellia serrata preparations and individual boswellic acids have been investigated for effects on 15-LOX-1 and the formation of specialised pro-resolving lipid mediators. This provides a broader and more precise picture than the older explanation of Boswellia mainly through 5-LOX.

Direct laboratory data for Boswellia dalzielii also include Pseudomonas aeruginosa, biofilm formation and LPS-stimulated responses in human immune cells. These findings are particularly interesting when comparing Boswellia with conifer resins, but they cannot automatically be transferred to other Boswellia species or to every preparation made from the resin.

More about species differences, composition and research is available on the Boswellia resin page.

The evidence profiles overlap, but they are not identical

The comparison therefore cannot be reduced to saying that spruce resin acts on microbes while Boswellia acts on inflammation. Both resins have evidence across several biological areas and their research profiles partly overlap.

The main difference lies in where the current evidence is strongest. Spruce and related Pinaceae resins have a particularly well-developed microbial, biofilm and tissue-biology evidence base, while Boswellia has a particularly rich triterpene, immune and lipid-mediator research space. This combination of overlap and difference is what makes direct comparison of the two resins scientifically interesting.

Comparison of Boswellia resin (left) and spruce resin (right). Colour, translucency and the presence of pieces of bark can vary between individual resin samples.

Yes, their biological profiles differ, but not in the simple sense that one resin acts only at the surface while the other acts only on inflammatory signalling pathways. Research on both resins points to effects at several biological levels, arising from very different chemical starting points.

Spruce resin links direct microbial effects with tissue responses

One particularly well-developed area for spruce resin and related conifer-resin materials is the antimicrobial and biofilm research space. Resin acids and their derivatives can affect microbial membranes and other structures, while appropriate experimental models have also shown effects on biofilm formation and established biofilms.

Spruce resin is not interesting only because of microbes. Compounds from Picea abies have also been investigated in relation to re-epithelialisation and keratinocyte migration, while dehydroabietic acid has been studied in human dermal fibroblasts under inflammatory conditions.

Its biological research profile therefore extends from direct effects on microorganisms to processes involved in tissue response and repair. Findings from an isolated resin acid, however, cannot automatically be attributed to the whole natural resin.

Boswellia opens a different triterpene and lipid-mediator research space

Boswellia starts from a different chemical basis. Boswellic and other triterpenic acids have been linked to several targets involved in inflammatory and innate immune responses. Investigated systems include mPGES-1 and PGE2, certain neutrophil enzymes, NF-κB and cytokine responses.

The classic explanation of Boswellia mainly through 5-LOX is now too narrow. Boswellic acids can inhibit 5-LOX in certain laboratory systems, but the effect is highly dependent on experimental conditions. More recent research therefore pays greater attention to the broader metabolism of lipid mediators.

Of particular interest is the pro-resolving pathway. Some Boswellia serrata preparations and individual boswellic acids have been studied for effects on 15-LOX-1 activity and on the formation of lipid mediators associated with the active resolution of inflammatory responses.

Direct evidence for Boswellia dalzielii also includes reductions in TNF-α, IL-6 and NF-κB in LPS-stimulated human immune cells, together with separate laboratory findings involving Pseudomonas aeruginosa and biofilms.

The difference lies in emphasis, not in a strict dividing line

Spruce resin should therefore not be described as merely “local” or “surface-acting”, nor Boswellia as merely “signalling” or “anti-inflammatory”. Both interact with several biological processes, and their research profiles partly overlap.

The more interesting distinction is that spruce and related Pinaceae chemistry has a particularly strong resin-acid, microbial, biofilm and tissue-biology research space, while Boswellia has a particularly rich triterpene, immune and lipid-mediator research space. This provides a much better rationale for investigating possible complementarity than dividing the two resins into two supposedly separate “mechanisms”.

There is a sound scientific rationale for combining spruce resin and Boswellia resin, but a direct advantage of the combination has not yet been demonstrated. The strongest reason to investigate them together is not their similarity but their difference: spruce resin is rooted primarily in a diterpene resin-acid chemical space, whereas Boswellia introduces a distinct pentacyclic triterpene system.

There is a good biological rationale for complementarity

Their best-supported biological profiles also differ. Spruce resin and related Pinaceae chemistry have a particularly well-developed antimicrobial, biofilm and tissue-biology research space, including re-epithelialisation and fibroblast responses.

Boswellia has a particularly rich triterpene, immune and lipid-mediator research space, including research on PGE2, certain neutrophil targets, cytokine responses and newer pro-resolving lipid pathways.

This makes spruce resin and Boswellia an interesting combination to investigate: two chemically distant systems may cover a broader biological space than either one alone. This is a scientifically grounded hypothesis of complementarity, not merely a marketing concept.

Complementarity is not the same as synergy

Separate studies of the two resins are not enough to show that their combination performs better than either resin alone. A direct combination experiment may produce an additive, synergistic, indifferent or antagonistic result.

True synergy means that the combined effect exceeds what would be expected from simple additivity of the individual components. This cannot be demonstrated merely by listing different chemical compounds or biological targets; the combination itself must be tested at multiple concentrations and ratios.

Formulation also matters

Resin systems add another important level: what is present in a formulation is not necessarily equally biologically available. Resin acids and boswellic acids are highly lipophilic compounds, so the vehicle, solubility, viscosity and distribution within the formulation can substantially alter their release.

Research on boswellic acids has shown that different formulations of the same active material can change its passage through skin several-fold. With conifer resins, poor water solubility is also known to strongly influence the apparent result of laboratory assays.

A combination therefore raises two separate questions: do the two chemical and biological systems complement each other, and are both actually released from the same formulation within a useful concentration range?

The best-supported conclusion at present is therefore that combining spruce resin and Boswellia has a strong research rationale for complementarity. Whether this translates into an additive advantage, true synergy or merely overlapping effects requires direct comparative testing.

With both resins, possible biological effects should be considered alongside the potential for irritation and sensitisation. For conifer resins, this issue is particularly well known because of colophony and related resin-acid materials.

Conifer resins have a recognised allergenic potential

Colophony is a recognised contact allergen. In the reviewed data, sensitisation to colophony occurs in approximately 1–3% of the general population, while rates may be higher in dermatology populations undergoing patch testing.

Allergic contact reactions have also been reported in clinical studies of spruce-resin ointments. One review reported such reactions in about 2% of treated patients, although the total number of participants was relatively small.

The basic resin acids are not the only relevant compounds. Oxidised derivatives of resin acids, which can form as resin ages and is exposed to air, are also important in the allergenic profile of colophony.

Allergy to spruce resin does not automatically mean allergy to Boswellia

Spruce resin and Boswellia resin belong to very different chemical systems. Spruce resin is dominated by a diterpene resin-acid space, whereas Boswellia is characterised by pentacyclic triterpenes and other components of an oleo-gum-resin.

An allergy to spruce resin or colophony therefore cannot automatically be transferred to Boswellia. At the same time, different chemistry alone does not prove that an individual cannot react to Boswellia.

If someone has previously had a clear allergic contact reaction to a resin, it is therefore more appropriate to regard a new resin as a different material rather than a guaranteed safe substitute.

What should you do if a reaction occurs?

If persistent redness, itching, swelling, blistering or another pronounced skin reaction develops after use, exposure should be stopped. A stronger, recurrent or unclear reaction is appropriately assessed by a dermatologist, with patch testing where indicated.

In general, it is not possible to say that one of the two resins is simply better. Spruce resin and Boswellia resin are chemically different materials with partly overlapping but differently developed research profiles.

For spruce resin, a particularly strong area of research concerns microorganisms, biofilms and processes involved in tissue response and repair. For Boswellia resin, the triterpene, immune and lipid-mediator research space is especially well developed.

This does not mean that either resin is limited to those areas. Their biological profiles partly overlap, and in both cases the result also depends on the specific resin material, extract, concentration and formulation.

A more useful question than “which is better?” is therefore: which resin or preparation has actually been studied for the process of interest, and what level of evidence supports it?

The substantial chemical difference between the two is also what makes their possible complementarity scientifically interesting. It does not, however, mean that a combination is necessarily better than either resin on its own.